Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
NovoCure Limited (NVCR) had Return on Equity of -12.99% for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
$133.78M |
|
$-47.08M |
|
$32.56M |
|
$101.23M |
|
$185.50M |
|
$-51.72M |
|
$13.18M |
|
$-38.53M |
|
$-38.53M |
|
$-47.08M |
|
$-47.08M |
|
$-47.08M |
|
$-47.08M |
|
$-51.72M |
|
$-56.26M |
|
106.39M |
|
106.39M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$1.03B |
|
$62.86M |
|
$111.72M |
|
$1.15B |
|
$179.12M |
|
$568.82M |
|
$604.52M |
|
$783.63M |
|
$362.50M |
|
$362.50M |
|
$362.50M |
|
107.08M |
|
| Cash Flow Statement Financials | |
$-73.34M |
|
$184.15M |
|
$15.79M |
|
$115.83M |
|
$242.56M |
|
$126.73M |
|
$115.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.78 |
|
-- |
|
-- |
|
0.61 |
|
1.57 |
|
75.67% |
|
-38.66% |
|
-38.66% |
|
-- |
|
-28.80% |
|
-35.19% |
|
$-100.43M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.85 |
|
1.59 |
|
56.44 |
|
|
Return on Equity |
-12.99% |
-12.99% |
|
-4.11% |
|
-5.06% |
|
$3.39 |
|
$-0.94 |
|
$-0.69 |
|